RENAU.UNSP.ARD 1/5 EO-20 (56S0) - Total Liabilities

Latest as of March 2026: €4.05 Billion EUR ≈ $4.73 Billion USD

Based on the latest financial reports, RENAU.UNSP.ARD 1/5 EO-20 (56S0) has total liabilities worth €4.05 Billion EUR (≈ $4.73 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

RENAU.UNSP.ARD 1/5 EO-20 - Total Liabilities Trend (2022–2025)

This chart illustrates how RENAU.UNSP.ARD 1/5 EO-20's total liabilities have evolved over time, based on quarterly financial data. See how liquid is RENAU.UNSP.ARD 1/5 EO-20's working capital to evaluate short-term liquidity relative to the company's equity base.

RENAU.UNSP.ARD 1/5 EO-20 Competitors by Total Liabilities

The table below lists competitors of RENAU.UNSP.ARD 1/5 EO-20 ranked by their total liabilities.

Company Country Total Liabilities
Banco Santander Chile
SN:BSANTANDER
Chile CL$65.00 Trillion
Hua Xia Bank Co Ltd
SHG:600015
China CN¥4.47 Trillion
PTT Exploration and Production Public Company Limited
F:NVAL
Germany €455.09 Billion
YANGTZE OPT.FIB.AND CAB.H
F:1YO
Germany €16.63 Billion
China International Capital Corp Ltd
SHG:601995
China CN¥665.02 Billion
Taiwan Union Technology
TWO:6274
Taiwan NT$26.20 Billion
Jde Peets Nv
AS:JDEP
Netherlands €12.90 Billion
Power Finance Corporation Limited
NSE:PFC
India Rs10.56 Trillion

Liability Composition Analysis (2022–2025)

This chart breaks down RENAU.UNSP.ARD 1/5 EO-20's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see RENAU.UNSP.ARD 1/5 EO-20 (56S0) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.03 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.99 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.49 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how RENAU.UNSP.ARD 1/5 EO-20's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for RENAU.UNSP.ARD 1/5 EO-20 (2022–2025)

The table below shows the annual total liabilities of RENAU.UNSP.ARD 1/5 EO-20 from 2022 to 2025.

Year Total Liabilities Change
2025-12-31 €3.86 Billion
≈ $4.51 Billion
-8.85%
2024-12-31 €4.23 Billion
≈ $4.95 Billion
-16.29%
2023-12-31 €5.06 Billion
≈ $5.91 Billion
+98.19%
2022-12-31 €2.55 Billion
≈ $2.98 Billion
--

About RENAU.UNSP.ARD 1/5 EO-20

F:56S0 Germany Medical Instruments & Supplies
Market Cap
$18.08 Billion
€15.47 Billion EUR
Market Cap Rank
#1610 Global
#347 in Germany
Share Price
€15.90
Change (1 day)
+1.27%
52-Week Range
€14.60 - €21.80
All Time High
€35.31
About

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transp… Read more